HOME › DRUGS › MOBOCERTINIB
ACTIVE SUBSTANCE / INN

MOBOCERTINIB

Brand name(s): Exkivity
EMA LISTED
APPLICATION WITHDRAWN
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Mobocertinib
REGULATORS
EMA
SPONSORS / MAH
Takeda Pharma A/S
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ExkivityTakeda Pharma A/SApplication withdrawnCarcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON MOBOCERTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →